K-ras oncogene codon 12 point mutations in testicular cancer.

por Ridanpää, M, Lothe, R A, Onfelt, A, Fosså, S, Børresen, A L, Husgafvel-Pursiainen, K
Publicado 1993

P-glycoprotein is not expressed in a majority of colorectal carcinomas and is not regulated by mutant p53 in vivo.

por De Angelis, P., Stokke, T., Smedshammer, L., Lothe, R. A., Lehne, G., Chen, Y., Clausen, O. P.
Publicado 1995

Strong HLA-DR expression in microsatellite stable carcinomas of the large bowel is associated with good prognosis

por Løvig, T, Andersen, S N, Thorstensen, L, Diep, C B, Meling, G I, Lothe, R A, Rognum, T O
Publicado 2002

The TP53 tumour suppressor gene in colorectal carcinomas. II. Relation to DNA ploidy pattern and clinicopathological variables.

por Meling, G. I., Lothe, R. A., Børresen, A. L., Graue, C., Hauge, S., Clausen, O. P., Rognum, T. O.
Publicado 1993

The TP53 tumour suppressor gene in colorectal carcinomas. I. Genetic alterations on chromosome 17.

por Meling, G. I., Lothe, R. A., Børresen, A. L., Graue, C., Hauge, S., Clausen, O. P., Rognum, T. O.
Publicado 1993

Genetic alterations within the retinoblastoma locus in colorectal carcinomas. Relation to DNA ploidy pattern studied by flow cytometric analysis.

por Meling, G. I., Lothe, R. A., Børresen, A. L., Hauge, S., Graue, C., Clausen, O. P., Rognum, T. O.
Publicado 1991

Assessment of clonal relationships in ipsilateral and bilateral multiple breast carcinomas by comparative genomic hybridisation and hierarchical clustering analysis

por Teixeira, M R, Ribeiro, F R, Torres, L, Pandis, N, Andersen, J A, Lothe, R A, Heim, S
Publicado 2004

Epigenetic and genetic features of 24 colon cancer cell lines

por Ahmed, D, Eide, P W, Eilertsen, I A, Danielsen, S A, Eknæs, M, Hektoen, M, Lind, G E, Lothe, R A
Publicado 2013

SPG20, a novel biomarker for early detection of colorectal cancer, encodes a regulator of cytokinesis

por Lind, G E, Raiborg, C, Danielsen, S A, Rognum, T O, Thiis-Evensen, E, Hoff, G, Nesbakken, A, Stenmark, H, Lothe, R A
Publicado 2011

CMS-dependent prognostic impact of KRAS and BRAF(V600E) mutations in primary colorectal cancer

por Smeby, J, Sveen, A, Merok, M A, Danielsen, S A, Eilertsen, I A, Guren, M G, Dienstmann, R, Nesbakken, A, Lothe, R A
Publicado 2018

Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal ca...

por Dienstmann, R, Villacampa, G, Sveen, A, Mason, M J, Niedzwiecki, D, Nesbakken, A, Moreno, V, Warren, R S, Lothe, R A, Guinney, J
Publicado 2019

Microsatellite instability has a positive prognostic impact on stage II colorectal cancer after complete resection: results from a large, consecutive Norwegian series

por Merok, M. A., Ahlquist, T., Røyrvik, E. C., Tufteland, K. F., Hektoen, M., Sjo, O. H., Mala, T., Svindland, A., Lothe, R. A., Nesbakken, A.
Publicado 2013

Prognostic impact of genomic instability in colorectal cancer

por Hveem, T S, Merok, M A, Pretorius, M E, Novelli, M, Bævre, M S, Sjo, O H, Clinch, N, Liestøl, K, Svindland, A, Lothe, R A, Nesbakken, A, Danielsen, H E
Publicado 2014

Prognostic markers for colorectal cancer: estimating ploidy and stroma

por Danielsen, H E, Hveem, T S, Domingo, E, Pradhan, M, Kleppe, A, Syvertsen, R A, Kostolomov, I, Nesheim, J A, Askautrud, H A, Nesbakken, A, Lothe, R A, Svindland, A, Shepherd, N, Novelli, M, Johnstone, E, Tomlinson, I, Kerr, R, Kerr, D J
Publicado 2018

Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study

por Dienstmann, R., Mason, M. J., Sinicrope, F. A., Phipps, A. I., Tejpar, S., Nesbakken, A., Danielsen, S. A., Sveen, A., Buchanan, D. D., Clendenning, M., Rosty, C., Bot, B., Alberts, S. R., Milburn Jessup, J., Lothe, R. A., Delorenzi, M., Newcomb, P. A., Sargent, D., Guinney, J.
Publicado 2017